iXPress Genes was awarded a Phase II Department of Defense Small Business Innovation contract to develop extremophile-derived novel antibiotics to protect soldiers from biowarfare agents.
Learn more here.
-
Follow
Following
Already have a WordPress.com account? Log in now.
Global Space Ventures 